UPB

Conviction 1HealthcareScan · Thu, Jun 25, 2026

UPB$6.34-0.16%

ResistanceSupportVol 14Insider sell

Vol MA14 742.52K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Upstream Bio, Inc.PHARMACEUTICAL PREPARATIONSwww.upstreambio.com ↗

Price6.34

Change-0.16%

Gap-0.16%

Rel volume1.07×

Avg volume689.88K

Avg $ vol4.6M

SMA 206.79

SMA 508.19

SMA 20017.32

Price vs 50-22.56%

Price vs 200-63.40%

MA stackbearish

50/200 cross—

Supertrenddown · 7.46

RSI (14)35

MACD hist0.06

MACD crossbull · 2d

Stoch %K / %D31 / 27

ADX (14)41

+DI / −DI12 / 24

RSI divergence—

MACD divergence—

ATR %+7.03%

ADR %6.49%

52w high32.60

52w low5.92

From 52w high-80.55%

Above 52w low+7.09%

New 52w highNo

SqueezeOff

Bollinger width45.05%

%B0.35

Donchian pos17.56%

Donchian high8.64

Donchian low5.85

AVWAP (52w high)11.51

vs AVWAP high-44.93%

AVWAP (52w low)6.25

vs AVWAP low+1.45%

OBV trendFlat

Chaikin MF (20)-0.33

Today vs 20d1.07×

Avg vol (14d)742.52K

Avg vol (20d)689.88K

Avg $ vol (20d)4.6M

Market cap345.02M

RS 3m (vs SPY)-37.11%

RS 6m (vs SPY)-86.10%

RS line new highNo

Trend template0/8

Technical rank7.5

1 week+3.09%

1 month-22.78%

3 months-33.05%

6 months-79.17%

1 year-44.34%

YTD-76.58%

P/E-2.41

P/B1.14

P/S120.89

P/FCF-2.59

EPS-2.66

Div yield—

ROE-47.19%

ROA-45.10%

Debt/Eq—

Current23.14

EV/EBITDA-1.55

Gross margin—

Net margin—

Rev growth20.42%

EPS growth-128.39%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value248.3M

Revenue1.03M

Net income-40.59M

Gross profit—

Free cash flow-133.44M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out54.42M

Employees75

ListedFri, Oct 11, 2024

Free float31.06M

Float %57.5%

Short interest3.64M

Days to cover6.8d

Short volume45.0%

Squeeze score53 / 100

Next earningsWed, Aug 5, 2026 (41d)

EPS forecast−$0.78 · 6 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction1 / 100

Pattern quality—

Tech rank7.5 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance9.56

Support6.52

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in UPB

All disclosures →

No recent disclosed trades by Congress in UPB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in UPB · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Ambrose Allison General Counsel · Common Stock · 2026-06-16	Sell	477	$3K	2026-06-16	2026-06-17

SEC filings

EDGAR filings in UPB · 1 recent

EDGAR →

8-K8-KWed, Jun 10, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.